SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
Clinical trial NCT06300411 · COMPLETED
Trial details
- NCT number
- NCT06300411
- Sponsor
- SURGE Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-29
- Primary completion
- 2026-04-08
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.